Table 6.

Participant exposure to the medicinal product

	IqYmune® N = 22	Kiovig® N = 21
Duration of IMP exposure (d)	169.0 (64.0, 176.0)	169.0 (164.0, 180.0)
Course frequency (wk)	4.0 (3.9, 8.3)	4.0 (4.0, 8.6)
Total number of courses	6.0 (2.0, 6.0)	6.0 (3.0, 6.0)
Total number of infusions	12.0 (6.0, 20.0)	12.0 (6.0, 20.0)
IMP dose per course (g/kg)	1.5 (1.0, 2.0)	1.4 (1.0, 2.0)
Cumulative IMP dose (g/kg)	6.3 (3.7, 11.6)	6.5 (3.7, 11.7)
Maximal flow rate over all infusions (mL/kg/h)	2.9 (1.0, 6.0)	3.1 (1.3, 6.0)

Abbreviations: IMP, investigated medicinal product.

The data shown are medians (min, max).